Rhenman & Partners Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30,000	Closed	-$1.29M	–	105
2017 Q2	$1.29M	Sell	30,000 -200,000	-87%	-$8.62M	0.19%	82
2017 Q1	$7.2M	Sell	230,000 -20,000	-8%	-$626K	1.14%	34
2016 Q4	$6.31M	Sell	250,000 -20,000	-7%	-$505K	1.21%	33
2016 Q3	$6.68M	Sell	270,000 -10,000	-4%	-$247K	1.06%	35
2016 Q2	$5.7M	Buy	280,000 +10,000	+4%	+$204K	1.01%	37
2016 Q1	$4.12M	Sell	270,000 -18,000	-6%	-$275K	0.82%	47
2015 Q4	$3.87M	Sell	288,000 -65,328	-18%	-$878K	0.59%	60
2015 Q3	$4.96M	Sell	353,328 -63,672	-15%	-$893K	0.79%	50
2015 Q2	$7.08M	Sell	417,000 -33,800	-7%	-$574K	0.85%	35
2015 Q1	$5.45M	Buy	450,800 +200,000	+80%	+$2.42M	0.92%	39
2014 Q4	$2.08M	Buy	250,800 +38,800	+18%	+$322K	0.6%	72
2014 Q3	$1.84M	Sell	212,000 -15,000	-7%	-$130K	0.54%	78
2014 Q2	$2.49M	Buy	227,000 +30,463	+15%	+$334K	0.74%	51
2014 Q1	$1.76M	Sell	196,537 -28,463	-13%	-$254K	0.53%	65
2013 Q4	$1.7M	Buy	+225,000	New	+$1.7M	0.66%	65